J&J, Guidant To Benefit From Medtronic's Rapid Exchange Market Pull-Out

Medtronic's immediate withdrawal from the rapid exchange delivery market in the U.S. opens the door for Johnson & Johnson/Cordis to take over the number-two spot in the coronary stent market.